Expression of aurora A kinase is correlated with cisplatin resistance in NSCLC: in vitro data of 102 NSCLC patients treated with surgery and adjuvant cisplatin-based chemotherapy showed that AURKA expression was elevated in cisplatin-resistant lung cancer cells. Here, AURKA is linked to non-small cell lung carcinoma.